ATE215952T1 - Hiv-proteaseinhibitoren - Google Patents
Hiv-proteaseinhibitorenInfo
- Publication number
- ATE215952T1 ATE215952T1 AT95905886T AT95905886T ATE215952T1 AT E215952 T1 ATE215952 T1 AT E215952T1 AT 95905886 T AT95905886 T AT 95905886T AT 95905886 T AT95905886 T AT 95905886T AT E215952 T1 ATE215952 T1 AT E215952T1
- Authority
- AT
- Austria
- Prior art keywords
- protease inhibitors
- compounds
- hiv protease
- hiv
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16801393A | 1993-12-15 | 1993-12-15 | |
| US17047593A | 1993-12-20 | 1993-12-20 | |
| PCT/US1994/014187 WO1995016688A1 (en) | 1993-12-15 | 1994-12-12 | Hiv protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE215952T1 true ATE215952T1 (de) | 2002-04-15 |
Family
ID=26863718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95905886T ATE215952T1 (de) | 1993-12-15 | 1994-12-12 | Hiv-proteaseinhibitoren |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5646148A (de) |
| EP (1) | EP0734387B1 (de) |
| JP (1) | JP3000564B2 (de) |
| KR (1) | KR100234863B1 (de) |
| CN (1) | CN1046727C (de) |
| AT (1) | ATE215952T1 (de) |
| AU (1) | AU692509B2 (de) |
| BG (1) | BG62093B1 (de) |
| BR (1) | BR9408305A (de) |
| CA (1) | CA2178760C (de) |
| CZ (1) | CZ288312B6 (de) |
| DE (1) | DE69430385T2 (de) |
| ES (1) | ES2174921T3 (de) |
| FI (1) | FI962488A0 (de) |
| HU (1) | HUT74681A (de) |
| NZ (1) | NZ278201A (de) |
| PL (1) | PL314984A1 (de) |
| SK (1) | SK75796A3 (de) |
| WO (1) | WO1995016688A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2235394A1 (en) | 1995-11-13 | 1997-05-22 | Gerard Voerman | Anti-viral isolates obtainable from leeches |
| MY126358A (en) * | 1996-03-22 | 2006-09-29 | Glaxo Group Ltd | Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs |
| TW438799B (en) * | 1997-05-29 | 2001-06-07 | Merck & Co Inc | HIV protease inhibitor |
| CO4940492A1 (es) * | 1997-05-29 | 2000-07-24 | Merck & Co Inc | Inhibidor de proteasa de vih |
| US6180634B1 (en) | 1997-11-13 | 2001-01-30 | Merck & Co., Inc. | Combination therapy for the treatment of AIDS |
| CO4970782A1 (es) * | 1997-11-13 | 2000-11-07 | Merck & Co Inc | Terapia combinada para el tratamiento del sida |
| US6251906B1 (en) | 1998-05-15 | 2001-06-26 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| FR2780649B1 (fr) * | 1998-07-06 | 2001-03-09 | Univ Paris Vii Denis Diderot | Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine |
| GB2341385A (en) | 1998-09-14 | 2000-03-15 | Merck & Co Inc | Recovery of iodide from chemical process waste water |
| US6440946B1 (en) * | 1999-02-25 | 2002-08-27 | Takeda Chemical Industries, Ltd. | Multiple-agents-binding compound, production and use thereof |
| US6589962B1 (en) | 1999-07-20 | 2003-07-08 | Merck & Co., Inc. | Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| ES2295068T3 (es) * | 1999-11-24 | 2008-04-16 | MERCK & CO., INC. | Gamma-hidroxi-2-(fluoroalquilaminocarbonil)-1-piperazinpentanamidas como inhibidores de la proteasa del vih. |
| US6482952B2 (en) | 2000-06-20 | 2002-11-19 | Merck & Co., Inc. | Process for preparing acetonides |
| US7049146B2 (en) | 2000-11-14 | 2006-05-23 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US7122376B2 (en) * | 2001-11-01 | 2006-10-17 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US20040131504A1 (en) * | 2002-09-17 | 2004-07-08 | Landers James P. | Remote temperature sensing of small volume and related apparatus thereof |
| GB0720503D0 (en) * | 2007-10-22 | 2007-11-28 | Angeletti P Ist Richerche Bio | New compound |
| US20130115237A1 (en) | 2010-06-09 | 2013-05-09 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment |
| CN108178764A (zh) * | 2018-01-09 | 2018-06-19 | 天津科技大学 | 呋喃并[2,3-b]吡啶类化合物及无金属催化的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
| WO1993008184A1 (en) * | 1991-10-23 | 1993-04-29 | Merck & Co., Inc. | Hiv protease inhibitors |
| DK0541168T3 (da) * | 1991-11-08 | 1998-05-11 | Merck & Co Inc | HIV-proteaseinhibitorer, som er egnede til behandling af AIDS |
| US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| CN1090186C (zh) * | 1993-03-31 | 2002-09-04 | 麦克公司 | 治疗aids药物组合物中的hiv蛋白酶抑制剂 |
-
1994
- 1994-12-12 DE DE69430385T patent/DE69430385T2/de not_active Expired - Fee Related
- 1994-12-12 CN CN94194954A patent/CN1046727C/zh not_active Expired - Fee Related
- 1994-12-12 AT AT95905886T patent/ATE215952T1/de not_active IP Right Cessation
- 1994-12-12 AU AU14331/95A patent/AU692509B2/en not_active Ceased
- 1994-12-12 BR BR9408305A patent/BR9408305A/pt not_active Application Discontinuation
- 1994-12-12 CZ CZ19961586A patent/CZ288312B6/cs not_active IP Right Cessation
- 1994-12-12 ES ES95905886T patent/ES2174921T3/es not_active Expired - Lifetime
- 1994-12-12 CA CA002178760A patent/CA2178760C/en not_active Expired - Fee Related
- 1994-12-12 NZ NZ278201A patent/NZ278201A/en unknown
- 1994-12-12 KR KR1019960703165A patent/KR100234863B1/ko not_active IP Right Cessation
- 1994-12-12 EP EP95905886A patent/EP0734387B1/de not_active Expired - Lifetime
- 1994-12-12 WO PCT/US1994/014187 patent/WO1995016688A1/en active Search and Examination
- 1994-12-12 JP JP7516855A patent/JP3000564B2/ja not_active Expired - Fee Related
- 1994-12-12 SK SK757-96A patent/SK75796A3/sk unknown
- 1994-12-12 PL PL94314984A patent/PL314984A1/xx unknown
- 1994-12-12 HU HU9601649A patent/HUT74681A/hu unknown
-
1995
- 1995-03-29 US US08/412,509 patent/US5646148A/en not_active Expired - Fee Related
-
1996
- 1996-06-05 BG BG100643A patent/BG62093B1/bg unknown
- 1996-06-14 FI FI962488A patent/FI962488A0/fi unknown
-
1997
- 1997-04-08 US US08/825,787 patent/US5807841A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1046727C (zh) | 1999-11-24 |
| FI962488A (fi) | 1996-06-14 |
| JP3000564B2 (ja) | 2000-01-17 |
| ES2174921T3 (es) | 2002-11-16 |
| WO1995016688A1 (en) | 1995-06-22 |
| CZ158696A3 (en) | 1996-11-13 |
| EP0734387A1 (de) | 1996-10-02 |
| US5807841A (en) | 1998-09-15 |
| CA2178760A1 (en) | 1995-06-22 |
| AU1433195A (en) | 1995-07-03 |
| SK75796A3 (en) | 1997-05-07 |
| BG62093B1 (bg) | 1999-02-26 |
| NZ278201A (en) | 1998-01-26 |
| DE69430385D1 (de) | 2002-05-16 |
| BG100643A (bg) | 1997-02-28 |
| KR100234863B1 (ko) | 1999-12-15 |
| HU9601649D0 (en) | 1996-08-28 |
| HUT74681A (en) | 1997-01-28 |
| US5646148A (en) | 1997-07-08 |
| DE69430385T2 (de) | 2002-11-07 |
| BR9408305A (pt) | 1997-08-26 |
| FI962488A0 (fi) | 1996-06-14 |
| CN1142827A (zh) | 1997-02-12 |
| EP0734387B1 (de) | 2002-04-10 |
| AU692509B2 (en) | 1998-06-11 |
| JPH09506619A (ja) | 1997-06-30 |
| CA2178760C (en) | 2000-08-01 |
| CZ288312B6 (en) | 2001-05-16 |
| PL314984A1 (en) | 1996-09-30 |
| EP0734387A4 (de) | 1997-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69228106D1 (de) | HIV-Protease-Inhibitoren | |
| ATE377011T1 (de) | Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1- piperazinpentanamide als hiv-proteasehemmer | |
| ATE215952T1 (de) | Hiv-proteaseinhibitoren | |
| ATE252081T1 (de) | Neue hiv-protease-inhibitoren | |
| MY109834A (en) | Benzoxazinones as inhibitors of hiv reverse transcriptase | |
| DZ1766A1 (fr) | Inhibiteurs de vih protéase utiles pour le traitement du sida. | |
| MX9705916A (es) | Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc. | |
| MX9700036A (es) | Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas. | |
| DK0774969T3 (da) | HIV-proteaseinhibitor kombination | |
| WO2002096359A3 (en) | Piperazine pentanamide hiv protease inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |